Загрузка видео...

Не удалось загрузить видео

На главную

🧬🔬 What exactly is this rejuvenation paradigm called “partial reprogramming” or “epigenetic rejuvenation” that has taken the longevity field by storm in the past few years with billion-dollar companies like Altos Labs dedicated to it, and visionary investors like Sam Altman, Brian Armstrong, Yuri Milner investing in it? This...

88,315 просмотров • 1 год назад •via X (Twitter)

Комментарии: 10

Фото профиля Yuri Deigin
Yuri Deigin1 год назад

See my full conversation with Iosif Gershteyn on Cognitum here (the clip starts at 10:50):

Фото профиля Yuri Deigin
Yuri Deigin1 год назад

If you are interested in partial reprogramming, check out this recent debate about the best longevity strategy to combat aging — partial reprogramming vs. replacement:

Фото профиля Jason Hreha
Jason Hreha1 год назад

@altos_labs @sama terrific explanation

Фото профиля Pavel Elad Zablotny
Pavel Elad Zablotny1 год назад

@altos_labs @sama Blows me away that your grandmother held and nurtured your egg inside her even before you mother was born. 🤯

Фото профиля Nomel-Cédric Beugré 👻✍️🔥
Nomel-Cédric Beugré 👻✍️🔥1 год назад

@altos_labs @sama Very clear explanation, thanks for sharing !

Фото профиля Davis Kelly 🧙🏼‍♂️🧙🏼‍♂️🍀
Davis Kelly 🧙🏼‍♂️🧙🏼‍♂️🍀1 год назад

@altos_labs @sama Yamanaka factors and totipotent stem cells. Throw back!

Фото профиля Art Deco Artist
Art Deco Artist1 год назад

@altos_labs @sama I'm 92, but when I get old one day, I may want to give this longevity thingy a try. 😎In the meantime I know that "My belief makes it so," "Thoughts are things," and "All things are possible." Follow to see my artwork.

Фото профиля Tony VanDongen
Tony VanDongen1 год назад

@altos_labs @sama The egg cell has the same age as the mother, but did it undergo the aging process as her somatic cells?

Фото профиля Sam
Sam1 год назад

@altos_labs @sama Would love if someone used an epigenetic clock to determine Pres Biden's biol. age. He looks and behaves much older than his chronological age. Maybe some of the new interventions could have saved his Presidential run

Фото профиля Sam
Sam1 год назад

@altos_labs @sama I bet Yamanaka factors are not the only factors that can reverse the deleterious epigenetic changes. There could be better ones with less risk. People haven't looked hard enough

Похожие видео

David Sinclair just announced at the World Government Summit that next month (March 2026), human clinical trials begin — the first in history to test whether we can reverse aging and cure diseases. His core claim: Aging isn't wear-and-tear like a car; it's like scratches on a CD. DNA is the music, but in old age, cells can't read it correctly — leading to confusion, wrong proteins, and disease. The breakthrough? They can "polish the CD" via partial epigenetic reprogramming (using Yamanaka factors like OSK) to restore youthful gene expression without altering DNA itself. Science nugget: In lab and animal studies (published 2020–2025), Sinclair's team reversed epigenetic age by up to 75% in six weeks in mouse optic nerves, restoring vision in blind animals. The approach reactivates youthful gene patterns while avoiding full cellular reprogramming risks like tumors. Current status: The FDA cleared Life Biosciences' Phase 1 trial (ER-100, Sinclair co-founded) in January 2026 for safety in patients with optic neuropathies (e.g., glaucoma, NAION). Enrollment starts soon, with initial results expected by late 2026/early 2027. This targets eye disease first — not whole-body aging — but success could open doors to broader rejuvenation. Sinclair envisions a future where kids with cancer gather under gentle plasma lights that shatter tumors painlessly, one cell at a time. Sci-fi becoming science fact? Are you hopeful this trial delivers — or skeptical it's overhyped?

Camus

22,258 просмотров • 4 месяцев назад

Today’s guest on the Free Radicals podcast is Michael Ringel, JD PhD, COO Life Biosciences and former Managing Director at Boston Consulting Group. Michael is a leader in longevity and pharma who spent 25+ years advising top pharma companies on their R&D strategy. He is now COO at Life Biosciences where he is bringing the first ever partial epigenetic reprogramming therapy to human clinical trials - a major milestone for the longevity industry. In this episode, we discuss Michael’s insightful paper on why aging is an optimization by evolution, why that means it’s malleable, and how to push the longevity field forward. Michael also sits on the US board of Hevolution Foundation and on the board of the AFAR. Be sure to follow me and Eric Dai to stay up to date on the latest news in longevity biotech! 0:00 Intro 2:30 Why aging is an optimization by evolution 15:10 Why scientists miss the role of evolution in aging 19:31 Evidence that aging is a regulated process 24:40 Hormesis and adaptive stress responses 28:55 The promise of partial epigenetic reprogramming in humans 35:08 Life Bio's first therapy proceeding to clinical trials 47:47 Why targeting the eye, particularly glaucoma and NION, is a strategic choice 52:03 The pharma industry's perspective on anti-aging research 56:39 The importance of public engagement for funding and policy change 1:05:42 Reasons for optimism in longevity 1:08:26 Advice on how to have an impactful and interdisciplinary career 1:11:54 The ethical case for longevity 1:17:34 Concrete steps for audience members to support longevity research

Daniel Shur

16,948 просмотров • 3 месяцев назад

David Sinclair says the first person to live to 150 is a teenager who's alive today. He's taken flak from colleagues for years over this prediction. He doesn't care. He still stands by it. "The first person to live to 150 has already been born." Here's why: A 14-year-old today has 80+ years of exponential technological progress ahead of them. Just look at what's happened in the last 10 years: • His lab reversed aging in monkey eyes by 95% • AI now does in 2 months what would have taken thousands of years. • His team has oral molecules that made old mice young again in 4 weeks • The first human age-reversal trial begins in January And that's just the beginning. There'll be more advancements in major medical technologies and therapies soon, including in: • Gene therapy • AI-designed drugs • Whole-body rejuvenation • Epigenetic reprogramming All of it will arrive within a teenager's lifetime. Sinclair believes this is a realistic projection of where the science is heading. Sinclair's advice for everyone is to stay healthy long enough to intercept what's coming. — David Sinclair (David Sinclair) on Peter Diamandis' (Peter H. Diamandis, MD) Moonshots podcast PS. David Sinclair is speaking at SynBioBeta on May 6th this year, discussing the science of slowing and reversing aging. If longevity is the world you're in, the investors, partners, and scientists shaping this space will be in the room. Grab your ticket in the comments below.

John Cumbers

84,263 просмотров • 2 месяцев назад

Scientists just figured out how to reverse aging using AI. And this is a massive breakthrough. We can now reprogram any human cell back to age 20. Heart cells, brain cells, skin cells, all reset to their biological prime. And here’s the wildest part…the technology to do this, has already existed since 2012 (it won the Nobel Prize). But the real breakthrough wasn’t possible until this year, when they supercharged it with AI. It’s a wild story. So in 2006, scientists discovered Yamanaka factors. They’re proteins that can basically convert any normal cell into a universal stem cell. Now this was a huge deal, because these stem cells are basically like magic healers. If you have torn muscle tissue, you could inject these stem cells into the area and they will turn into the youthful muscle cells you need. So Yamanaka factors were this insane breakthrough, because they allowed any human to turn any cell you already have into these magic healers. But, there was one big problem… It turns out, the original Yamanaka factors weren’t very good at this stem cell conversion. They could do it, but they just weren’t very reliable. Enter OpenAI...and this is where things get crazy. OpenAI designed a special AI model built specifically to create new proteins. Think of it like ChatGPT but for protein engineering. So they took all the Yamanaka research and asked this new AI to go ham on improving it. And get this… Their version was 50x more effective than the original. They tested it on 50 year old cells and it successfully started repairing 30% of their cells in just 7 days. This is just science fiction…it actually happened. And it sounds crazy, but in a few years, humans will be able to take a shot that will literally reverse the age of their cells.

Whiplash347

68,643 просмотров • 8 месяцев назад